Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine

作者: Segev Barak , Ina Weiner

DOI: 10.1007/S00213-010-1785-Z

关键词: Acetylcholine receptorLatent inhibitionConditioningMuscarinic antagonistPhysostigmineStimulus (physiology)PharmacologyMuscarinic acetylcholine receptorChemistryPsychosis

摘要: Rationale Latent inhibition (LI) is the poorer conditioning to a stimulus seen when preceded by repeated non-reinforced pre-exposure stimulus. LI indexes ability ignore irrelevant stimuli and used extensively model attentional impairments in schizophrenia. We showed that pro-psychotic muscarinic antagonist scopolamine can produce disruption or persistence depending on dose stage of administration: low doses disrupt acting procedure, whereas higher produces abnormally persistent via action stage. The two abnormalities show distinct response antipsychotic drugs (APDs), with disruption, but not persistence, reversed APDs.

参考文章(74)
Angela K. Sellin, Mujeeb Shad, Carol Tamminga, Muscarinic agonists for the treatment of cognition in schizophrenia Cns Spectrums. ,vol. 13, pp. 985- 996 ,(2008) , 10.1017/S1092852900014048
Kiyoshi Ando, Naoyuki Hironaka, Effects of cholinergic drugs on scopolamine-induced memory impairment in rhesus monkeys. Japanese journal of psychopharmacology. ,vol. 16, pp. 103- 108 ,(1996)
Laurie M. Nishimura, Roland J. Boegman, release of acetylcholine from the medial septum/diagonal band of rat brain Neuroscience Letters. ,vol. 115, pp. 259- 264 ,(1990) , 10.1016/0304-3940(90)90465-L
Jouni Sirviö, Tommi Ekonsalo, Paavo Riekkinen, Hannele Lahtinen, Paavo Riekkinen, D-cycloserine, a modulator of the N-methyl-D-aspartate receptor, improves spatial learning in rats treated with muscarinic antagonist. Neuroscience Letters. ,vol. 146, pp. 215- 218 ,(1992) , 10.1016/0304-3940(92)90081-H
N Matsuoka, T G Aigner, D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics. ,vol. 278, pp. 891- 897 ,(1996)